Depletion of natural killer cells from the graft reduces interferon-γ levels and lipopolysaccharide-induced tumor necrosis factor-α release in f1 hybrid mice with acute graft-versus-host disease

Transplantation

Volumn 66, Issue 3, 1998, Pages 284-294

  Ellison, Cynthia A ^a   Hayglass, Kent T ^a   Fischer, Jacqie M M ^a   Rector, Edward S ^a   Macdonald, Glen C ^a   Gartner, John G ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CACHEXIA; FEMALE; GRAFT VERSUS HOST REACTION; HELPER CELL; IMMUNE RESPONSE; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 0032529638     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00002     Document Type: Article

References (58)

1. Gallagher MT, Richie ER, Trentin JJ. Inhibition of allograft reactivity in vitro and in vivo by Fab fragments obtained from ALG. Transplant Proc 1973; 5: 869.
2. Martin PJ, Hansen JA, Buckner CD, et al. Effects of in vitro depletion of T cells in HLA-identical allograft marrow grafts. Blood 1985; 66: 664.
3. Papa G, Arcese W, Mauro FR, et al. Standard conditioning regimen and T-depleted donor marrow for transplantation in chronic myeloid leukemia. Leukoc Res 1986; 10: 1469.
4. Lopez C, Kirkpatrick D, Sorell M, O'Reilly JR, Ching C. Association between pretransplant natural killer and graft-versus-host disease after stem cell transplantation. Lancet 1979; 24: 1103.
5. Charley MR, Mikhael A, Bennett M, Gilliam JN, Sontheimer RD. Prevention of lethal, minor determinant graft-versus-host disease by the in vivo administration of anti-asialo GM1. J Immunol 1983; 131: 101.
6. Ghayur T, Seemayer TA, Kongshavn PAL, Gartner JG, Lapp WS. Graft-versus-host reactions in the beige mouse: an investigation of the role of donor natural killer cells in the pathogenesis of graft-versus-host disease. Transplantation 1987; 44: 261.
7. Gartner JG, Merry AC, Smith CI. An analysis of pulmonary natural killer-cell activity in F1-hybrid mice with acute graft-versus-host reactions. Transplantation 1988; 88: 4606.
8. + cells of donor origin. Transplantation 1988; 45: 586.
9. 1 hybrid mice by pretreatment of the graft with anti-NK-1.1 and complement. Transplantation 1992; 54: 147.
10. + NK-like cell with a broadened spectrum of lytic activity in the spleen and lymph nodes. Scand J Immunol 1991; 33: 553.
11. Ghayur T, Seemayer TA, Lapp WS. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction: relationship between natural killer cell activity, and T and B cell activity, and the development of histopathological alterations. Transplantation 1987; 44: 254.
12. Doukas J, Cutler AH, Mordes JP. Polyinosinic:polycytidylic acid is a potent activator of endothelial cells. Am J Pathol 1994; 145: 137.
13. Gromkowski SH, Mama K, Yagi J, Sen R, Rath S. Antitumour activity of endotoxin, concanavalin A and poly I:C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo. Cancer Immunol Immunother 1983; 16: 35.
14. Djeu JY, Heinbaugh JA, Holden HT, Herberman RB. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 1979; 122: 175.
15. + cells on a magnetic cell separator (MACS). J Immunol Methods 1995; 186: 233.
16. Ellison CA, MacDonald GC, Rector ES, Gartner JG. γδ T cells in the pathobiology of murine acute graft-versus-host disease: evidence that γδ T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality. J Immunol 1995; 155: 4189.
17. Blazar B, Soderling CCB, Koo G, Vallera DA. Absence of a facilitory role for NK 1.1-positive donor cells in engraftment across a major histocompatibility barrier in mice. Transplantation 1988; 45: 876.
18. Nestel FP, Price KS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor α during graft-versus-host disease. J Exp Med 1992; 175: 405.
19. Bradley LM. Mixed lymphocyte responses. In: Mishell BB, Shiigi MS, eds. Selected methods in cellular immunology. San Francisco: W.H. Freeman and Company, 1980: 162.
20. Yang X, Giene RS, Mosmann TR, HayGlass KT. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J Exp Med 1993; 178: 349.
21. + T cells. J Immunol 1995; 155: 2396.
22. + T cells upon NKR-P1 cross-linking. J Exp Med 1996; 183: 2391.
23. lck-mediated tyrosine phosphorylation and IFN-gamma production. J Immunol 1995; 155: 5241.
24. Scott P. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 1991; 147: 3149.
25. H1 cells. Sci. 1995; 269: 245.
26. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 547.
27. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13: 251.
28. + T cells. Annu Rev Immunol 1994; 12: 635.
29. O'Garra A, Murphy K. Role of lymphokines in determining T lymphocyte function. Curr Opin Immunol 1994; 6: 458.
30. Trinchieri G. Recognition of major histocompatibility complex class I antigens by natural killer cells. J Exp Med 1994; 180: 417.
31. Burkowski JF, Woda BA, Habu S, Okumura K, Welsh RM. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983; 131: 1531.
32. Kirkpatrick CE, Farrell JP, Warner JF, Dennert G. Participation of natural killer cells in recovery of mice from visceral leishmaniasis. Cell Immunol 1985; 92: 163.
33. Dunn PL, North RJ. Early gamma interferon production by natural killer cells is important in defense against murine listerosis. Infect Immun 1991; 59: 2892.
34. Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: a T-cell-independent pathway of macrophage activation defined in the scid mouse. Immunol Rev 1991; 124: 5.
35. Lasky T, Rollinghof M, Solbach W. Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur JImmunol 1993; 23: 2237.
36. + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993; 178: 567.
37. + cells as effectors of IFN-γ dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J Exp Med 1993; 178: 1465.
38. Varkila K, Chatelain R, Leal LMCC, Coffman RL. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur J Immunol 1993; 23: 262.
39. D'Orazio JA, Burke GW, Stein-Streilein J. Staphylococcal enterotoxin B activates purified NK cells to secrete IFNγ but requires T lymphocytes to augment NK cytotoxicity. J Immunol 1995; 141: 3349.
40. Cleveland MG, Annable CR, Klimpel GR. In vivo and in vitro production of IFN-β and IFN-γ during graft vs. host disease. J Immunol. 1988; 141: 3349.
41. McCarthy PL Jr, Abhyankar S, Neben S, et al. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 1991; 78: 1915.
42. Via CS. Kinetics of T cell activation in acute and chronic forms of graft-versus-host disease. J Immunol 1991; 146: 2603.
43. Piguet PF, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/ cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 1987; 166: 1280.
44. Kichian K, Nestel FP, Kim D, Ponka P, Lapp WS. IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease: possible involvement of IFN-γ. J Immunol 1996; 157: 2851.
45. Ferrara JLM. Cytokine dysregualtion as a mechanism of graft-versus-host disease. Curr Opin Immunol 1993; 5: 794.
46. Symington FW, Symington BE, Liu PY, Viguet H, Santhanam U, Sehgal PB. The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation. Transplantation 1992; 54: 457.
47. Garside P, Hutton AK, Severn A, Liew FY, Mowat AM. Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur J Immunol 1992; 22: 2141.
48. Gartner JG, Adamson IYR, Bowden DH. Proliferation of pulmonary macrophages during the early phase of an acute graft-versus-host reaction in mice. Exp Lung Res 1988; 14: 781.
49. Holler E, Kolb HJ, Hintermeier-Knabe R, et al. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant Proc 1993; 25: 1234.
50. Oliff A, Defeo-Jones D, Boyer M, et al. Tumors secreting human TNF-/cachectin induce cachexia in mice. Cell 1987; 50: 555.
51. + lymphoid engraftment. J Immunol 1994; 152: 1004.
52. Mowat AM, Felstein MV. Intestinal graft-versus-host disease. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Graft-vs.-host disease. New York: Marcel Dekker, 1997: 337.
53. Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993; 11: 571.
54. Seaman WE, Sleisenger M, Ericksson E, Koo GC. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1: reduction in host defense against malignancy without loss of cellular or humoral immunity. J Immunol 1987; 138: 4539.
55. - cells. J Exp Med 1997; 179: 1957.
56. Blazar B, Taylor PA, Panoskaltsis-Mortari A, Barrett TA, Bluestone JA, Vallera DA. Lethal murine graft-versus-host disease induced by donor γ/δ expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens. Blood 1996; 87: 827.
57. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune function in mice with disrupted interferon-gamma genes. Science 1993; 259: 1739.
58. 1-hybrid model using IFN-γ gene knockout donors. J Immunol 1998; 161: 631.